SARS-CoV-2 NSP8 Polyclonal Antibody (2019-nCoV)
This is a SARS-CoV-2 NSP8 (2019-nCoV) Virus Antibody from Reddot Biotech. This product is for Research Use Only.
Product Specifications
Background
Cleavage by the viral main protease, 3CLpro results in generating the nsp8 protein, The nsp8 protein has been shown to associate with several other nsps and to colocalize with these nsps in cytoplasmic complexes that are important for viral RNA synthesis. It forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers. Nsp8 was shown to have RNA-dependent RNA polymerase (RdRp) activity that could be involved in producing primers utilized by nsp12 which is normally accepted to be the RdRp for SARS-CoV.
Synonyms
Non-structural protein 8, Replicase polyprotein 1a
Reactivity
SARS-COV2
Immunogen
Recombinant SARS-CoV-2 NSP8
Clonality
Polyclonal
Conjugation
Unconjugated
Type
Virus Antibody
Applications
ELISA
Purification Method
Produced in rabbits immunized with purified, Recombinant SARS-CoV-2 NSP8
Assay Type
Antibody
Concentration
0.93mg/mL
Dilution
ELISA 1:4000-1:8000
Buffer
PBS, pH7.4, containing 0.05% proclin300, 50% glycerol.
Storage Conditions
Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Host or Source
Rabbit
Isotype
IgG
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog